How does microneedling work?

Microneedling is often described in one sentence: tiny needles create tiny injuries, and the skin responds by repairing itself. That explanation is broadly correct, but it leaves out the part that matters most to patients — what is actually being treated, how controlled needling differs from simply damaging the skin, why results are gradual and why not every concern responds equally well.

Traditional microneedling uses a sterile device with multiple fine needles to create controlled punctures in the skin. These punctures initiate a wound-healing response that can influence collagen remodelling and the architecture of scarred or photoaged skin. The procedure is used most commonly for concerns such as atrophic acne scarring, uneven texture, selected fine lines and, in some protocols, stretch marks.

The treatment is not the same as radiofrequency microneedling. Traditional microneedling relies on mechanical needling alone, whereas RF microneedling combines needles with radiofrequency energy delivered into the tissue. The two approaches have different devices, evidence, risk profiles and treatment goals, so they should not be presented as interchangeable.

Contents

Microneedling uses multiple sterile needles to repeatedly enter and leave the skin at controlled depths. Devices may be manual or motorised. Pen-style systems move needles vertically, while rollers move needles across the skin as the cylinder rotates. The practical purpose is the same: to create many controlled micro-injuries without intentionally removing the whole surface layer of skin.

The treatment is sometimes called percutaneous collagen induction or collagen-induction therapy. That name is useful, but it can also oversimplify the biology. The skin response involves inflammation, signalling, cell migration, extracellular-matrix remodelling and later collagen reorganisation. The visible result, where treatment is effective, develops gradually rather than immediately.

The word “injury” can sound alarming, but the central concept is control. The aim is not to create as much trauma as possible. It is to create a reproducible stimulus while preserving surrounding tissue. Needle depth, pass number, pressure, device settings and treatment density should be selected for the area and indication rather than increased simply to make the skin look more inflamed.

This is also why deeper does not automatically mean better. A superficial texture concern does not necessarily require the same depth as an atrophic scar, and delicate areas may need a different approach from thicker facial or body skin. Excessive trauma can increase discomfort, prolonged redness, pigmentary change, infection risk and scarring.

The early response begins with haemostasis and inflammation. Platelets and inflammatory cells release signalling molecules involved in repair. Over the following days and weeks, fibroblasts and other cells contribute to extracellular-matrix remodelling, while collagen organisation evolves over a longer period.

This helps explain why the skin can look red immediately after treatment while the intended structural change is not yet visible. Redness is an acute response; collagen remodelling is slower. Any meaningful improvement should therefore be judged after the initial inflammation has settled and enough time has passed for tissue remodelling.

Manual rollers and automated pens use the same broad principle but move through the skin differently. Rollers enter along the arc of a rotating cylinder. Motorised pens move needles vertically and usually allow more precise adjustment of depth. The clinical significance is not that one category is universally superior; it is that device design affects control, reproducibility and how the operator treats different areas.

Professional treatment also differs from cosmetic home-rolling. Medical or professional microneedling may use greater depths and requires appropriate infection-control procedures, device handling and patient selection. Deeper needling should not be replicated at home simply because a commercial device is available.

Microneedling is frequently marketed for a long list of concerns, but the quality of evidence is not equal across them. The most defensible way to discuss results is by indication. Atrophic acne scars have a substantial body of clinical literature. Facial rejuvenation, wrinkles, photoageing and stretch marks also have published evidence, but study protocols and outcome measures are heterogeneous.

Atrophic acne scarring is one of the most studied indications for microneedling. Systematic reviews have generally found improvement in scar appearance, including when microneedling is used alone and when it forms part of combination treatment. However, studies use different scar scales, devices, depths, treatment intervals and combination protocols, so results should not be reduced to one guaranteed percentage.

Scar type also matters. Rolling and some boxcar scars may respond differently from narrow ice-pick scars or scars tethered to deeper structures. A scar consultation should therefore classify the scar pattern rather than treating “acne scars” as one uniform condition.

Microneedling is also used for facial rejuvenation, but the language here needs to stay measured. A 2025 systematic review of 21 studies and 723 patients found that wrinkles, texture and photoageing were among the most commonly studied outcomes. The overall literature suggests that some patients report improvement in these areas, but study quality, protocols and follow-up vary.

It is more accurate to describe these changes as gradual improvements in skin quality than as “lifting” or reversal of ageing. Traditional microneedling does not reposition facial tissues, remove excess skin or restore deep structural volume. If laxity, volume loss or another structural issue is the dominant concern, a different treatment category may be more relevant.

Stretch marks, or striae distensae, represent dermal scarring rather than simply “damaged surface skin”. Microneedling has been studied as a way of remodelling the affected tissue. A 2024 systematic review and meta-analysis found initial evidence of benefit, although the included studies used different microneedling and RF-microneedling approaches and the evidence does not support a promise of complete removal.

Body treatment also requires practical adjustments. Skin thickness, body area, scar age, colour, previous treatment and individual pigmentation tendency all influence planning. The face, neck, décolletage and body should not automatically receive identical settings simply because they are being treated with the same device.

A professional session begins with assessment rather than with the device. Active inflammatory acne, infection, recent procedures, medications, history of abnormal scarring, pigmentary risk and the exact treatment goal can all change whether treatment should proceed and how it should be performed.

The sensation varies with depth, area, device and individual sensitivity. Patients may describe vibration, scratching, heat or repeated sharp sensations. Topical anaesthetic may be used for deeper treatment, but microneedling should not be marketed as universally painless.

Redness, warmth, tightness, tenderness, mild swelling and pinpoint bleeding can occur after treatment. The duration varies with treatment intensity and the individual. Redness for 24–72 hours and a 3–5 day healing period may be reasonable examples for some protocols, but they should not be treated as universal timelines.

Aftercare should protect the recovering skin barrier. The exact instructions depend on the device and depth, but commonly include gentle cleansing, avoiding unnecessary friction or picking, sun protection and temporarily withholding irritating actives such as retinoids or exfoliating acids. Makeup timing should follow the treating clinician’s protocol rather than a universal internet rule.

It is also important not to assume that any serum is appropriate immediately after needling. The US FDA notes that authorised microneedling devices have not been cleared for delivery of cosmetics, topical medications, vitamin solutions, drugs or biologics into the skin. Products used around a procedure should therefore be selected deliberately rather than applied simply because open microchannels are present.

Microneedling is not appropriate for every patient at every time. Active infection, uncontrolled inflammatory skin disease in the treatment area, open wounds, active herpes lesions, some bleeding disorders, relevant immunosuppression, poor wound healing, a history of problematic scarring or certain medicines may change suitability. Pregnancy and breastfeeding may also influence whether an elective cosmetic procedure is postponed.

This list is not a substitute for medical assessment. Patients should not stop prescription medication or supplements on their own before treatment. The correct approach is to disclose the medication and let the treating clinician decide whether further medical review is needed.

In England, microneedling is included within the Government’s proposed licensing framework for non-surgical cosmetic procedures. As of the latest published consultation response, the final scheme still requires secondary legislation before the new licensing restrictions come into force. Traditional microneedling was proposed in the lower-risk category, while hybrid technologies such as RF microneedling were treated separately because combining technologies changes the risk profile.

RF microneedling uses needle electrodes to deliver radiofrequency energy into or beneath the skin. The mechanical puncture and the thermal effect happen together. This means the treatment should not be described simply as “stronger microneedling” or as an automatic upgrade. It is a separate energy-based procedure with different settings, indications and complications.

In October 2025, the FDA issued a safety communication after reports of serious complications with certain RF microneedling uses, including burns, scarring, fat loss, disfigurement and nerve damage. The agency’s review is ongoing. That warning does not mean every RF microneedling treatment causes these problems, but it does mean the procedure should not be trivialised or presented as equivalent in risk to traditional mechanical microneedling.

Microneedling is one of several approaches to skin resurfacing and remodelling. Chemical peels, fractional lasers, RF microneedling, subcision and combination protocols can all be relevant depending on the problem. The choice should follow the diagnosis rather than a general claim that one treatment has “less downtime” or is “better for every skin tone”.

For acne scars, recent network meta-analyses continue to show that several modalities can improve outcomes, and combination treatment can be useful for mixed scar patterns. For stretch marks, recent meta-analyses suggest microneedling can achieve improvement comparable with some laser approaches in selected studies, but results remain heterogeneous. These data support microneedling as a legitimate option, not as a universally superior one.

Microneedling works by creating controlled micro-injuries that trigger repair and tissue remodelling. That mechanism is real, but it does not make every claim about “collagen”, “rejuvenation” or skin tightening automatically valid. The most useful treatment plan starts with the indication, chooses an appropriate device and depth, respects the skin’s healing capacity and sets expectations according to the evidence rather than the marketing language.

References / Further Reading